Russo, Luis Augusto T

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Del Prato, S., Kahn, S. E., Pavo, I., Weerakkody, G. J., Yang, Z., Doupis, J., Aizenberg, D., Wynne, A. G., Riesmeyer, J. S., Heine, R. J., et al. (2021) · The Lancet

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 684

Fracture risk and zoledronic acid therapy in men with osteoporosis

Boonen, S., Reginster, J.-Y., Kaufman, J.-M., Lippuner, K., Zanchetta, J., Langdahl, B., Rizzoli, R., Lipschitz, S., Dimai, H. P., Witvrouw, R., et al. (2012) · New England Journal of Medicine

Bone health and osteoporosis researchBone health and treatments

Cited by 359

A randomized, double-blind, multicenter, placebo-controlled study to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of osteoporosis in postmenopausal women taking calcium and vitamin D

Henriksen, K., Byrjalsen, I., Andersen, J. R., Bihlet, A. R., Russo, L. A., Alexandersen, P., Valter, I., Qvist, P., Lau, E., Riis, B. J., et al. (2016) · Bone

Bone health and osteoporosis researchMenopause: Health Impacts and Treatments

Cited by 78

Increased epicardial adipose tissue in type 1 diabetes is associated with central obesity and metabolic syndrome

Momesso, D. P., Bussade, I., Epifanio, M. A., Schettino, C. D. S., Russo, L. A. T., & Kupfer, R. (2011) · Diabetes Research and Clinical Practice

Cardiovascular Disease and AdiposityAdipokines, Inflammation, and Metabolic Diseases

Cited by 42